CRNC · Cerence Inc.
$7.93
-0.21 (-2.58%)
At close · Jul 29
Market Cap
$367.83M
Shares
45.19M
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | Filing Date | Period | Open |
|---|---|---|---|
| 8-K | 2026-07-02 | 2026-06-28 | |
| 10-Q | 2026-05-07 | 2026-03-31 | |
| 8-K | 2026-05-07 | — | |
| 8-K | 2026-02-18 | 2026-02-12 | |
| 10-Q | 2026-02-05 | 2025-12-31 | |
| 8-K | 2026-02-04 | — | |
| DEF 14A | 2026-01-02 | 2025-09-30 | |
| 8-K | 2025-12-29 | 2025-12-23 | |
| 10-K | 2025-11-20 | 2025-09-30 | |
| 8-K | 2025-11-19 | — | |
| 8-K | 2025-11-03 | 2025-10-28 | |
| 8-K | 2025-09-05 | 2025-09-02 | |
| 10-Q | 2025-08-06 | 2025-06-30 | |
| 8-K | 2025-08-06 | — | |
| 8-K | 2025-05-07 | — | |
| 10-Q | 2025-05-07 | 2025-03-31 | |
| 8-K | 2025-03-20 | 2025-03-17 | |
| 8-K | 2025-02-18 | 2025-02-13 | |
| 8-K | 2025-02-06 | — | |
| 10-Q | 2025-02-06 | 2024-12-31 | |
| DEF 14A | 2024-12-31 | 2025-02-13 | |
| 8-K | 2024-12-23 | — | |
| 8-K | 2024-12-03 | 2024-11-29 | |
| 10-K | 2024-11-25 | 2024-09-30 | |
| 8-K | 2024-11-21 | — | |
| 8-K | 2024-10-07 | 2024-10-06 | |
| 10-Q | 2024-08-09 | 2024-06-30 | |
| 8-K | 2024-08-08 | — | |
| 8-K | 2024-07-02 | 2024-06-26 | |
| 8-K | 2024-06-04 | — | |
| 8-K | 2024-05-16 | 2024-05-11 | |
| 10-Q | 2024-05-10 | 2024-03-31 | |
| 8-K/A | 2024-05-09 | — | |
| 8-K | 2024-05-09 | — | |
| 8-K | 2024-04-15 | 2024-04-12 | |
| 8-K | 2024-03-04 | 2024-02-28 | |
| 8-K | 2024-02-20 | 2024-02-15 | |
| 10-Q | 2024-02-08 | 2023-12-31 | |
| 8-K | 2024-02-06 | — | |
| DEF 14A | 2024-01-05 | 2024-02-15 | |
| 10-K | 2023-11-29 | 2023-09-30 | |
| 8-K | 2023-11-27 | — | |
| 10-Q | 2023-08-09 | 2023-06-30 | |
| 8-K | 2023-08-08 | — | |
| 8-K | 2023-06-26 | — | |
| 8-K | 2023-06-22 | 2023-06-21 | |
| 8-K | 2023-06-01 | 2023-05-31 | |
| 10-Q | 2023-05-09 | 2023-03-31 | |
| 8-K | 2023-05-09 | — | |
| 8-K | 2023-05-04 | 2023-04-28 |
Showing 1–50 of 99 filings
Key facts
CIK
1768267
CUSIP
156727109
13F (30d)
40 filings
40 filers
Visit website
Investor relations